IEG Policy is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

White House directs feds to update key biotech policy document

The administration’s goals in the first year are to clarify the roles and responsibilities of the agencies that regulate the products of biotechnology, to formulate a long-term biotechnology strategy and to commission an independent analysis of the “future landscape” of biotechnology products. The independent analysis will identify potential new risks and areas in which the risks or lack of risks relating to the products of biotechnology are well understood, the memo says. Because of the rapid pace of change, an external analysis should be completed at least every five years, the memo says.

Advertisement

Topics

What to read next

UsernamePublicRestriction

Register

PL021389

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel